These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

669 related items for PubMed ID: 23524209

  • 1. Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Banerjee A, Fauchier L, Vourc'h P, Andres CR, Taillandier S, Halimi JM, Lip GY.
    J Am Coll Cardiol; 2013 May 21; 61(20):2079-87. PubMed ID: 23524209
    [Abstract] [Full Text] [Related]

  • 2. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V, Marín F, Manzano-Fernández S, Gallego P, Vílchez JA, Valdés M, Vicente V, Lip GY.
    J Am Coll Cardiol; 2013 Dec 10; 62(23):2199-204. PubMed ID: 24055744
    [Abstract] [Full Text] [Related]

  • 3. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
    Piccini JP, Stevens SR, Chang Y, Singer DE, Lokhnygina Y, Go AS, Patel MR, Mahaffey KW, Halperin JL, Breithardt G, Hankey GJ, Hacke W, Becker RC, Nessel CC, Fox KA, Califf RM, ROCKET AF Steering Committee and Investigators.
    Circulation; 2013 Jan 15; 127(2):224-32. PubMed ID: 23212720
    [Abstract] [Full Text] [Related]

  • 4. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
    Potpara TS, Polovina MM, Licina MM, Marinkovic JM, Prostran MS, Lip GY.
    Circ Arrhythm Electrophysiol; 2012 Apr 15; 5(2):319-26. PubMed ID: 22319004
    [Abstract] [Full Text] [Related]

  • 5. Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project.
    Banerjee A, Taillandier S, Olesen JB, Lane DA, Lallemand B, Lip GY, Fauchier L.
    Int J Cardiol; 2013 Sep 10; 167(6):2682-7. PubMed ID: 22795403
    [Abstract] [Full Text] [Related]

  • 6. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
    Bonde AN, Lip GY, Kamper AL, Hansen PR, Lamberts M, Hommel K, Hansen ML, Gislason GH, Torp-Pedersen C, Olesen JB.
    J Am Coll Cardiol; 2014 Dec 16; 64(23):2471-82. PubMed ID: 25500231
    [Abstract] [Full Text] [Related]

  • 7. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Piorkowski C, Gaspar T, Lip GY, Bollmann A.
    Circ Arrhythm Electrophysiol; 2013 Oct 16; 6(5):868-74. PubMed ID: 24047706
    [Abstract] [Full Text] [Related]

  • 8. Vascular disease and stroke risk in atrial fibrillation: a nationwide cohort study.
    Olesen JB, Lip GY, Lane DA, Køber L, Hansen ML, Karasoy D, Hansen CM, Gislason GH, Torp-Pedersen C.
    Am J Med; 2012 Aug 16; 125(8):826.e13-23. PubMed ID: 22579139
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
    Friberg L, Rosenqvist M, Lip GY.
    Eur Heart J; 2012 Jun 16; 33(12):1500-10. PubMed ID: 22246443
    [Abstract] [Full Text] [Related]

  • 10. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB, Torp-Pedersen C, Hansen ML, Lip GY.
    Thromb Haemost; 2012 Jun 16; 107(6):1172-9. PubMed ID: 22473219
    [Abstract] [Full Text] [Related]

  • 11. Chronic kidney disease and CHADS(2) score independently predict cardiovascular events and mortality in patients with nonvalvular atrial fibrillation.
    Nakagawa K, Hirai T, Takashima S, Fukuda N, Ohara K, Sasahara E, Taguchi Y, Dougu N, Nozawa T, Tanaka K, Inoue H.
    Am J Cardiol; 2011 Mar 15; 107(6):912-6. PubMed ID: 21247518
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for stroke and thromboembolism in relation to age among patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Olesen JB, Fauchier L, Lane DA, Taillandier S, Lip GYH.
    Chest; 2012 Jan 15; 141(1):147-153. PubMed ID: 21680645
    [Abstract] [Full Text] [Related]

  • 13. Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).
    Roldán V, Marín F, Fernández H, Manzano-Fernández S, Gallego P, Valdés M, Vicente V, Lip GY.
    Am J Cardiol; 2013 Apr 15; 111(8):1159-64. PubMed ID: 23337836
    [Abstract] [Full Text] [Related]

  • 14. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
    Roldán V, Marín F, Manzano-Fernandez S, Fernández H, Gallego P, Valdés M, Vicente V, Lip GY.
    Thromb Haemost; 2013 May 15; 109(5):956-60. PubMed ID: 23572113
    [Abstract] [Full Text] [Related]

  • 15. Identifying patients at high risk for stroke despite anticoagulation: a comparison of contemporary stroke risk stratification schemes in an anticoagulated atrial fibrillation cohort.
    Lip GY, Frison L, Halperin JL, Lane DA.
    Stroke; 2010 Dec 15; 41(12):2731-8. PubMed ID: 20966417
    [Abstract] [Full Text] [Related]

  • 16. R2CHADS2 score and thromboembolic events after catheter ablation of atrial fibrillation in comparison with the CHA2DS2-VASc score.
    Chao TF, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Liao JN, Chung FP, Hsieh MH, Chen SA.
    Can J Cardiol; 2014 Apr 15; 30(4):405-12. PubMed ID: 24582725
    [Abstract] [Full Text] [Related]

  • 17. Stroke risk stratification in a "real-world" elderly anticoagulated atrial fibrillation population.
    Poli D, Lip GY, Antonucci E, Grifoni E, Lane D.
    J Cardiovasc Electrophysiol; 2011 Jan 15; 22(1):25-30. PubMed ID: 20653814
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the reliability and validity of four contemporary risk stratification schemes to predict thromboembolism in non-anticoagulated patients with atrial fibrillation.
    Abu-Assi E, Otero-Raviña F, Allut Vidal G, Coutado Méndez A, Vaamonde Mosquera L, Sánchez Loureiro M, Caneda Villar MC, Fernández Villaverde JM, Maestro Saavedra FJ, González-Juanatey JR, Grupo Barbanza researchers.
    Int J Cardiol; 2013 Jun 05; 166(1):205-9. PubMed ID: 22104995
    [Abstract] [Full Text] [Related]

  • 19. CHADS2 and CHA2DS2-VASc risk factors to predict first cardiovascular hospitalization among atrial fibrillation/atrial flutter patients.
    Naccarelli GV, Panaccio MP, Cummins G, Tu N.
    Am J Cardiol; 2012 May 15; 109(10):1526-33. PubMed ID: 22360819
    [Abstract] [Full Text] [Related]

  • 20. A prospective study of estimated glomerular filtration rate and outcomes in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Banerjee A, Fauchier L, Vourc'h P, Andres CR, Taillandier S, Halimi JM, Lip GYH.
    Chest; 2014 Jun 15; 145(6):1370-1382. PubMed ID: 24356875
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.